معرفی
Anna Wedell is a Professor in Medical Genetics at the Department of Molecular Medicine and Surgery, Karolinska Institutet, and Head of the Centre for Inherited Metabolic Diseases (CMMS) at Karolinska University Hospital. She holds senior clinical roles, including Senior Consultant and Head of Clinic at CMMS. Her research focuses on inborn errors of metabolism, clinical whole genome sequencing, neurometabolism, mitochondrial disorders, and personalized medicine.
Education: MD from Karolinska Institutet (1988), PhD in Medical Sciences (1994), and licensed specialist in Clinical Genetics (2006).
Key Positions: Chair of the Nobel Committee for Physiology or Medicine (2016–2018), member of Royal Swedish Academy of Sciences and Engineering Sciences, and International Commission on Human Germline Genome Editing.
Awards: Research!Sweden Researcher of the Year (2019), Honorary Skou Professor (2019), Nicholson Lecturer (2018), and Wallenberg Clinical Scholar (2015).
Research Interests: Her work integrates clinical genetics with advanced genomic technologies to diagnose and treat metabolic disorders. Key areas include mitochondrial dysfunction, metabolic pathway defects, and translational applications of whole genome sequencing in acute care. She leads multidisciplinary teams investigating neurometabolic disorders and personalized therapeutic strategies.
Mentoring: Supervises 6 current PhD students and 2 postdocs, with prior mentorship of 11 PhD students and 5 postdocs. Active in training clinicians and researchers in clinical genetics and genomic medicine.
Lab/Treatments: Directs the CMMS, a clinical and research hub for inherited metabolic diseases, and contributes to the Science for Life Laboratory’s genomic initiatives.
